Capital International Sarl’s Novartis NVS Stock Holding History

Capital International Sarl’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-184	Closed	-$12K	–	145
2016 Q4	$12K	Sell	184 -1,116	-86%	-$72.4K	﹤0.01%	146
2016 Q3	$92K	Hold	1,300	–	–	0.01%	162
2016 Q2	$96K	Hold	1,300	–	–	0.01%	163
2016 Q1	$84K	Hold	1,300	–	–	0.01%	157
2015 Q4	$100K	Hold	1,300	–	–	0.01%	157
2015 Q3	$107K	Hold	1,300	–	–	0.01%	159
2015 Q2	$115K	Hold	1,300	–	–	0.01%	163
2015 Q1	$115K	Hold	1,300	–	–	0.01%	159
2014 Q4	$108K	Hold	1,300	–	–	0.01%	158
2014 Q3	$110K	Hold	1,300	–	–	0.01%	151
2014 Q2	$105K	Hold	1,300	–	–	0.01%	148
2014 Q1	$99K	Hold	1,300	–	–	0.01%	144
2013 Q4	$94K	Buy	1,300 +446	+52%	+$31K	0.01%	136
2013 Q3	$59K	Hold	854	–	–	﹤0.01%	137
2013 Q2	$54K	Buy	+854	New	+$55.6K	﹤0.01%	135

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Capital International Sarl's NVS Position: Q1 2017 in Review

Capital International Sarl sold out of Novartis (NVS) in Q1 2017, closing a stake of 184 shares — an estimated $12K sold.

Capital International Sarl first reported a position in NVS in Q2 2013 and held it in 15 quarters. The position peaked at $115K in Q2 2015. 910 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

Capital International Sarl reported no remaining Novartis position as of Q1 2017 after selling out during the quarter.
Capital International Sarl sold 184 Novartis shares in Q1 2017, an estimated $12K.
Capital International Sarl first reported a position in Novartis in Q2 2013 and held it in 15 quarters.
Capital International Sarl's Novartis position peaked at $115K in Q2 2015.
910 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Capital International Sarl's 13F filing for Q1 2017, filed 15 May 2017.